Tag: Advanced Proteome Therapeutics

November 14, 2018

Advanced Proteome Expands Partnership with Heidelberg

Advancing this partnership is based off of the companies also announcing positive results from an animal study.
November 14, 2018

Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma

Advanced Proteome Therapeutics (TSXV:APC) (FSE: 0E8), is pleased to announce very positive results from animal studies in collaboration with Heidelberg...
September 13, 2018

Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative

Advanced Proteome Therapeutics (TSXV:APC) (FSE:0E8), is pleased to report significant progress in applying the Company’s site-selective linker technology to advance...
February 5, 2018

Relevium Improves Financial Position and Provides Updates on Warrants Exercises

Advanced Proteome Therapeutics (TSXV:APC) is pleased to announce that the Japanese Patent Office has decided to grant a patent for...
January 31, 2018

Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum

Advanced Proteome Therapeutics (TSXV:APC) announces that during the 2017 calendar year, it has witnessed very significant progress in APC’s scientific program...
July 31, 2017

Advanced Proteome Therapeutics Shares Corporate Update

Advanced Proteome Therapeutics announced the election of its board of directors form the shareholders annual general meeting and provided an...
July 18, 2017

Advanced Proteome Therapeutics Enters Collaboration to Develop Cancer Therapeutic

Advanced Proteome Therapeutics announced a collaboration with the National Research Council of Canada for the development of antibody-drug conjugates.